Context: The American Board of Medical Specialties Maintenance of Certification (MOC) process will become effective in 2006. The College of American Pathologists (CAP) Education Committee defined pathology-specific competencies within MOC categories and used data from a survey of pathologists to create education courses targeted to each MOC category.
Objective: To define pathology-specific competencies within MOC categories and to identify priority learning needs for pathologists.
Design: A 5-step process was completed for defining pathology-specific competencies within MOC categories and creating education courses targeted to competencies identified in each MOC category. A random survey was distributed to identify priority learning needs based on the gap between the importance rating of each knowledge and skill statement and a rating of current level of proficiency in 3 areas.
Results: Specific competencies and knowledge and skill statements were identified for each MOC competency category. Findings indicate pathologists believe they are poorly prepared for practice in competency categories related to systems-based practice and practice-based learning and improvement.
Conclusions: The CAP has focused education efforts on identifying a process for defining and responding to the MOC challenge. Pathologists have told us that they have significant needs for learning in specified areas and the CAP will focus development of education courses to meet those identified needs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5858/2005-129-0666-ATMOCC | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pathology-specific lipid alterations with triacylglycerol as a potential biomarker in Focal cortical dysplasia (FCD) and Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS).
Neuroscience
February 2025
Dr. B.R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi, Delhi, India. Electronic address:
Focal Cortical Dysplasia (FCD) & Mesial Temporal Lobe Epilepsy-Hippocampal Sclerosis (MTLE-HS) are two common pathologies of drug-resistant focal epilepsy (DRE). Inappropriate localization of the epileptogenic zones (EZs) in FCD is a significant contributing factor to the unsatisfactory surgical results observed in FCD cases. Currently, no molecular or cellular indicators are available which can aid in identifying the epileptogenic zones (EZs) in FCD.
View Article and Find Full Text PDFIntracranial multimodal monitoring in neurocritical care (Neurocore-iMMM): an open, decentralized consensus.
Crit Care
December 2024
Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Background: Intracranial multimodal monitoring (iMMM) is increasingly used in neurocritical care, but a lack of standardization hinders its evidence-based development. Here, we devised core outcome sets (COS) and reporting guidelines to harmonize iMMM practices and research.
Methods: An open, decentralized, three-round Delphi consensus study involved experts between December 2023 and June 2024.
Protocol for the quantitative analysis of images retrieved by multiplex immunofluorescence staining to allow cell type-specific spatial phenotyping of markers of interest in the human placenta.
Placenta
September 2024
Department of Obstetrics, University Hospital Jena, 07747, Jena, Germany. Electronic address:
In contrast to other tissues, the placenta consists of numerous functionally different cell types, distributed in a markedly dissimilar manner within one placenta and between different cases. To evaluate pathology-specific changes in cell phenotype and expression of molecular markers it is important to establish a multi staining method combining immunohistological identification of the cell type with staining of proteins of interest. We successfully established a protocol for a 6-plex antibody panel for multiplex immunofluorescence.
View Article and Find Full Text PDFIn vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives.
Alzheimers Dement
August 2024
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Introduction: The recent introduction of seed amplification assays (SAAs) detecting misfolded α-synuclein, a pathology-specific marker for Lewy body disease (LBD), has allowed the in vivo identification and phenotypic characterization of patients with co-occurring Alzheimer's disease (AD) and LBD since the early clinical or even preclinical stage.
Methods: We reviewed studies with an in vivo biomarker-based diagnosis of AD-LBD copathology.
Results: Studies in large cohorts of cognitively impaired individuals have shown that cerebrospinal fluid (CSF) biomarkers detect the coexistence of AD and LB pathology in approximately 20%-25% of them, independently of the primary clinical diagnosis.
Immune subtyping of melanoma whole slide images using multiple instance learning.
Med Image Anal
April 2024
School of Computing, University of Leeds, Woodhouse, Leeds, LS2 9JT, United Kingdom.
Article Synopsis
- Researchers are tackling the challenges of finding early-stage markers and effectively treating melanoma by using deep learning to analyze standard pathology slides instead of costly transcriptome data.
- They developed models that classify these slides into immune subgroups and achieved promising results, showing a strong ability to predict patient survival outcomes based on their immune classification.
- This approach could enhance clinical workflows by identifying important biomarkers and helping clinicians understand tumor immune landscapes without the need for expensive genetic tests.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!